Localz, leading experts in last-mile location and messaging technology, have partnered with MRI Software, a global leader…
Month: August 2022
Valo Therapeutics Announces Scientific Advisory Board
Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases,…
Positive Results Announced from Phase III IMscin001 Study Evaluating Subcutaneous Formulation of Tecentriq® with ENHANZE® in Advanced Non-Small Cell Lung Cancer
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Roche’s Phase III IMscin001 study evaluating a subcutaneous…
Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19
TADIOS was determined to be safe and well tolerated Serum levels of IL-1RA changed significantly, a…
MetroPlusHealth Expands Free Access to Dietitians to City Workers & Their Families Under Gold Plan
With healthy food costs and diet-related illnesses on the rise in the City, MetroPlusHealth, New York City’s high-quality and…